2024•GastroenterologyRequires access

Sa1624 SWITCHING TO TENOFOVIR (TAF) THERAPY VS. CONTINUING WITH ENTECAVIR (ETV) THERAPY IN ENTECAVIR-TREATED CHRONIC HEPATITIS B PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Muhammad Shahzil, Ammad Chaudhary, Anza Muhammad, Talha Kashif, Ali Akram Qureshi, Faiza Khan, Muhammad Faisal, Hassam Ali, Muhammad Sheharyar Warraich

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Entecavir, Tenofovir, Medicine, Chronic hepatitis, Meta-analysis, Internal medicine, Virology, Lamivudine

Back to paper search Browse research topics Original source

Sa1624 SWITCHING TO TENOFOVIR (TAF) THERAPY VS. CONTINUING WITH ENTECAVIR (ETV) THERAPY IN ENTECAVIR-TREATED CHRONIC HEPATITIS B PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS — Research Paper | ScholarLens